Systemic inflammatory response syndrome criteria and vancomycin dose requirement in patients with sepsis

Intensive Care Medicine

Volumn 39, Issue 7, 2013, Pages 1247-1252

  Shimamoto, Yuko ^a   Fukuda, Tsuyoshi ^b,c   Tanaka, Kazuhiko ^d   Komori, Katsuya ^a   Sadamitsu, Daikai ^a  

^a OSAKA NATIONAL HOSPITAL   (Japan)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Augmented renal clearance; Clearance; Sepsis; SIRS criteria; Vancomycin; Vancomycin dosage

Indexed keywords

CREATININE; VANCOMYCIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BAYES THEOREM; CHEMOTHERAPY; CORRELATION ANALYSIS; CREATININE CLEARANCE; DISTRIBUTION VOLUME; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG MONITORING; FEMALE; HUMAN; INTERMITTENT POSITIVE PRESSURE VENTILATION; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; OBSERVATIONAL STUDY; PATIENT ASSESSMENT; SCORING SYSTEM; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VENTILATED PATIENT;

ADULT; AGE FACTORS; ANTI-BACTERIAL AGENTS; BAYES THEOREM; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LINEAR MODELS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; MULTIVARIATE ANALYSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VANCOMYCIN;

EID: 84879119267     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-013-2909-9     Document Type: Article

References (20)

1. Kirby WM (1984) Vancomycin therapy of severe staphylococcal infections. J Antimicrob Chemother 14(Suppl D):73-78
2. Brumfitt W, Hamilton-Miller J (1989) Methicillin-resistant Staphylococcus aureus. N Engl J Med 320(18):1188-1196
3. Matzke GR, Zhanel GG, Guay DR (1986) Clinical pharmacokinetics of vancomycin. Clin Pharmacokinet 11(4):257-282
4. Matzke GR, McGory RW, Halstenson CE, Keane WF (1984) Pharmacokinetics of vancomycin in patients with various degrees of renal function. Antimicrob Agents Chemother 25(4):433-437
5. Rodvold KA, Blum RA, Fischer JH, Zokufa HZ, Rotschafer JC, Crossley KB, Riff LJ (1988) Vancomycin pharmacokinetics in patients with various degrees of renal function. Antimicrob Agents Chemother 32(6):848-852
6. Roberts JA, Lipman J (2006) Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis. Clin Pharmacokinet 45(8):755-773
7. Nystrom PO (1998) The systemic inflammatory response syndrome: definitions and aetiology. J Antimicrob Chemother 41(Suppl A):1-7
8. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20(6):864-874
9. Yasuhara M, Iga T, Zenda H, Okumura K, Oguma T, Yano Y, Hori R (1998) Population pharmacokinetics of vancomycin in Japanese adult patients. Ther Drug Monit 20(2):139-148
10. Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16(1):31-41
11. Udy AA, Roberts JA, Boots RJ, Paterson DL, Lipman J (2010) Augmented renal clearance: implications for antibacterial dosing in the critically ill. Clin Pharmacokinet 49(1):1-16
12. Baptista JP, Sousa E, Martins PJ, Pimentel JM (2012) Augmented renal clearance in septic patients and implications for vancomycin optimisation. Int J Antimicrob Agents 39(5):420-423
13. Troger U, Drust A, Martens-Lobenhoffer J, Tanev I, Braun-Dullaeus RC, Bode-Boger SM (2012) Decreased meropenem levels in intensive care unit patients with augmented renal clearance: benefit of therapeutic drug monitoring. Int J Antimicrob Agents 40(4):370-372
14. Udy AA, Putt MT, Boots RJ, Lipman J (2011) ARC - augmented renal clearance. Curr Pharm Biotechnol 12(12):2020-2029
15. Udy AA, Roberts JA, Lipman J (2011) Implications of augmented renal clearance in critically ill patients. Nat Rev Nephrol 7(9):539-543
16. Varghese JM, Roberts JA, Lipman J (2011) Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock. Crit Care Clin 27(1):19-34
17. Roberts JA, Lipman J (2009) Pharmacokinetic issues for antibiotics in the critically ill patient. Crit Care Med 37(3):840-851
18. Knudsen JD, Fuursted K, Raber S, Espersen F, Frimodt-Moller N (2000) Pharmacodynamics of glycopeptides in the mouse peritonitis model of Streptococcus pneumoniae or Staphylococcus aureus infection. Antimicrob Agents Chemother 44(5):1247-1254
19. Moise-Broder PA, Forrest A, Birmingham MC, Schentag JJ (2004) Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections. Clin Pharmacokinet 43(13):925-942
20. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53(6):982-992